Patent ID: 8765754

Claim:
A compound represented by formula (I) wherein ring1 represents benzene which is optionally substituted with 1-5 substituent(s) selected from the group consisting of halogen, a C1-4 alkyl, CF 3 , nitrile, CONH 2 , and OR 5-103 ; R 1 represents halogen or a C1-4 alkoxy; L represents —O— or —S—; R 2 represents (1) a C1-4 alkyl substituted with OR 5-103 , (2) C2-4 alkenyl, or (3) ring2 optionally substituted with one or more —K—R 3 ; ring2 represents (1) a C4-7 carbocyclic ring or (2) a 4-7 membered heterocyclic ring, any atom of which is optionally substituted with one or more oxo group; K represents bond, a C1-4 alkylene, —C(O)CH 2 —, —C(O)CH 2 CH 2 —, —C(O)O—, —CH 2 C(O)—, —CH 2 C(O)O—, —C(O)—, —CH 2 O—, —CH 2 CH 2 O—, —O—, —OCH 2 —, —OCH 2 C(O)— or —SO 2 —, wherein the left bond binds to ring2; R 3 represents (1) hydrogen, (2) NR 3-101 R 3-102 , (3) a C1-4 alkyl optionally substituted with NR 3-101 R 3-102 , (4) a C2-4 alkenyl optionally substituted with NR 3-101 R 3-102 , (5) CF 3 , (6) nitrile, (7) halogen, or (8) a cyclic ring optionally substituted with 1-5 substituent(s) selected from the group consisting of halogen, a C1-4 alkyl, a C1-4 alkoxy, CF 3 , nitrile and oxo, wherein the cyclic ring is selected from the group consisting of morpholine, pyrrolidine, benzene, piperazine, tetrahydropyran, piperidine, tetrahydrofuran, oxazole, thiazole, pyrazole and oxadiazole; R 4 represents (1) halogen, (2) CONR 4-101 R 4-102 , (3) CO 2 R 4-103 , (4) ring3, (5) a C1-4 alkyl which is substituted with 1-5 substituent(s) selected from ring4, nitrile, NR 4-101 R 4-102 , CONR 4-101 R 4-102 , COR 4-103 , COR 4-103 , OR 4-103 , SOR 4-103 , and SO 2 R 4-103 , or (6) a C2-4 alkenyl which is substituted with 1-5 substituent(s) selected from ring4, nitrile, NR 4-101 R 4-102 , CONR 4-101 R 4-102 , CO 2 R 4-103 , COR 4-103 , OR 4-103 , SOR 4-103 and SO 2 R 4-103 ; R 3-101 and R 3-102 each independently represent (1) hydrogen, (2) a C1-4 alkyl, (3) COR 3-103 , (4) CONR 3-103 R 3-104 or (5) SO 2 R 3-103 , wherein R 3-103 and R 3-104 each independently represent hydrogen or a C1-4 alkyl; R 4-101 , R 4-102 and R 4-103 each independently represent (1) hydrogen, (2) COR 5-103 , (3) NR 5-101 R 5-102 , (4) ring5, or (6) a C1-4 alkyl optionally substituted with CO 2 R 5-103 , OR 5-103 , or NR 5-101 R 5-102 ; R 5-101 , R 5-102 and R 5-103 each independently represent hydrogen or a C1-4 alkyl; ring3, ring4 and ring5 each independently represent a 4-7 membered heterocyclic ring optionally substituted with 1-5 substituent(s) selected from the group consisting of halogen, oxo, a C1-4 alkyl, a C1-4 alkoxy, CF 3 , CONR 5-101 R 5-102 , CO 2 R 5-103 , SOR 5-103 , SO 2 R 5-103 and nitrile; n represents 0 or 1; a salt thereof or a solvate thereof.